Total Payments
$615,851
2024 Payments
$6,439
Companies
72
Transactions
1,791
Medicare Patients
6,671
Medicare Billing
$869,704
Payment Breakdown by Category
Other$528,397 (85.8%)
Food & Beverage$36,959 (6.0%)
Consulting$34,358 (5.6%)
Travel$15,314 (2.5%)
Education$824.37 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $527,897 | 302 | 85.7% |
| Food and Beverage | $36,959 | 1,352 | 6.0% |
| Consulting Fee | $34,358 | 19 | 5.6% |
| Travel and Lodging | $15,314 | 100 | 2.5% |
| Education | $824.37 | 17 | 0.1% |
| Honoraria | $500.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $123,648 | 156 | $0 (2022) |
| GENZYME CORPORATION | $95,620 | 172 | $0 (2023) |
| ABBVIE INC. | $74,765 | 131 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $64,554 | 231 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $54,693 | 77 | $0 (2019) |
| US WorldMeds, LLC | $39,788 | 80 | $0 (2020) |
| EMD Serono, Inc. | $30,414 | 79 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $22,333 | 21 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $20,363 | 43 | $0 (2021) |
| Allergan, Inc. | $18,981 | 61 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,439 | 17 | ABBVIE INC. ($5,498) |
| 2023 | $24,565 | 107 | IMPEL PHARMACEUTICALS INC. ($9,176) |
| 2022 | $51,180 | 118 | ABBVIE INC. ($16,598) |
| 2021 | $103,102 | 275 | AbbVie Inc. ($44,557) |
| 2020 | $71,682 | 287 | Teva Pharmaceuticals USA, Inc. ($16,420) |
| 2019 | $137,724 | 363 | Amgen Inc. ($56,231) |
| 2018 | $119,384 | 318 | Amgen Inc. ($39,463) |
| 2017 | $101,777 | 306 | GENZYME CORPORATION ($31,461) |
All Payment Transactions
1,791 individual payment records from CMS Open Payments — Page 1 of 72
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $83.76 | General |
| 11/20/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $130.70 | General |
| Category: Neurology | ||||||
| 09/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $47.95 | General |
| Category: PAIN | ||||||
| 07/31/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $79.12 | General |
| 06/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: PAIN | ||||||
| 05/30/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $124.20 | General |
| Category: Immunology | ||||||
| 04/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: PAIN | ||||||
| 04/22/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 04/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $94.83 | General |
| Category: PAIN | ||||||
| 03/27/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $83.84 | General |
| Category: Neurology | ||||||
| 03/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $123.20 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $82.54 | General |
| Category: Rare Disease | ||||||
| 02/05/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $66.52 | General |
| Category: Immunology | ||||||
| 12/14/2023 | MDD US Operations, LLC | APOKYN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,260.00 | General |
| Category: NEUROLOGY | ||||||
| 12/07/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $106.50 | General |
| 11/10/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $83.55 | General |
| Category: Neurology | ||||||
| 11/01/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $124.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $121.59 | General |
| Category: Immunology | ||||||
| 10/05/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $66.15 | General |
| Category: EPILEPSY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,340 | 2,063 | $327,882 | $155,958 |
| 2022 | 18 | 1,462 | 2,325 | $388,916 | $188,922 |
| 2021 | 19 | 1,901 | 3,416 | $549,117 | $281,546 |
| 2020 | 20 | 1,968 | 3,126 | $475,972 | $243,279 |
Total Patients
6,671
Total Services
10,930
Medicare Billing
$869,704
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 440 | 615 | $117,465 | $50,883 | 43.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 232 | 650 | $67,600 | $38,880 | 57.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 126 | 136 | $39,576 | $17,106 | 43.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 117 | 126 | $24,948 | $11,839 | 47.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 28 | 36 | $11,520 | $5,840 | 50.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $11,115 | $5,212 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 87 | $11,658 | $4,671 | 40.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 48 | $7,152 | $4,100 | 57.3% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2023 | 29 | 29 | $8,729 | $4,080 | 46.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 77 | 87 | $8,004 | $3,712 | 46.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 48 | 98 | $7,252 | $3,371 | 46.5% |
| 95912 | Nerve conduction, 11-12 studies | Facility | 2023 | 20 | 20 | $5,080 | $2,374 | 46.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $4,539 | $2,040 | 44.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 25 | 37 | $2,220 | $1,419 | 63.9% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 16 | 32 | $1,024 | $430.08 | 42.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 249 | 755 | $112,495 | $58,786 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 451 | 655 | $125,105 | $56,330 | 45.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 185 | 208 | $41,184 | $21,279 | 51.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 25 | 49 | $15,680 | $8,180 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 127 | $17,018 | $7,163 | 42.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 95 | 107 | $9,844 | $4,666 | 47.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $9,633 | $4,431 | 46.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 35 | $9,345 | $4,163 | 44.5% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2022 | 29 | 29 | $8,729 | $4,136 | 47.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 53 | 53 | $7,738 | $4,056 | 52.4% |
About Dr. Dhruv Patel, M.D
Dr. Dhruv Patel, M.D is a Specialist healthcare provider based in Lorain, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699740613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dhruv Patel, M.D has received a total of $615,851 in payments from pharmaceutical and medical device companies, with $6,439 received in 2024. These payments were reported across 1,791 transactions from 72 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($527,897).
As a Medicare-enrolled provider, Patel has provided services to 6,671 Medicare beneficiaries, totaling 10,930 services with total Medicare billing of $869,704. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Neurology
- Location Lorain, OH
- Active Since 02/22/2006
- Last Updated 01/22/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1699740613
Products in Payments
- Aimovig (Biological) $123,462
- AUBAGIO (Drug) $95,280
- UBRELVY (Drug) $80,861
- ACTHAR (Biological) $77,025
- APOKYN (Drug) $44,365
- AJOVY (Biological) $34,790
- NURTEC ODT (Drug) $19,628
- COPAXONE (Drug) $18,872
- NUEDEXTA (Drug) $18,580
- Fycompa (Drug) $16,368
- Trudhesa (Drug) $16,273
- QULIPTA (Drug) $12,533
- Rebif (Biological) $11,792
- Mavenclad (Biological) $10,626
- AJOVY (Drug) $10,064
- Mavenclad (Drug) $7,213
- ONZETRA Xsail (Drug) $1,852
- TYSABRI (Biological) $1,529
- AIMOVIG (Biological) $628.54
- OCREVUS (Biological) $608.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Lorain
Dr. Osama Malak, M.d, M.D
Specialist — Payments: $5,602
Specialist $5,602
Abdul Razack, M.d, M.D
Specialist — Payments: $4,518
Specialist $4,518
Dr. Julie Pruneski, D.d.s, D.D.S
Specialist — Payments: $4,214
Specialist $4,214
Dr. Bharat Shah, M.d, M.D
Specialist — Payments: $3,703
Specialist $3,703
Dr. John Bell, M.d, M.D
Specialist — Payments: $1,124
Specialist $1,124
Dr. Demostenes Sison, Md, MD
Specialist
Specialist